EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Hematological Parameters After Transcatheter Aortic Valve Replacement

Mehmet Zülküf Karahan, Adem Aktan iD, Tuncay Güzel iD, Raif Kılıç, Serhat Günlü, Muhammed Demir, Faruk Ertaş

Angiology · 2024

DOI: 10.1177/00033197231177397 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angiology, 2024. Verfasst von Mehmet Zülküf Karahan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Mardin Artuklu University Faculty of Medicine, Mardin, Turkey. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Hemoglobins. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although transcatheter aortic valve replacement (TAVR) is safe and effective, mortality and bleeding events post procedure are important. The present study investigated the changes in hematologic parameters to evaluate whether they predict mortality or major bleeding. We enrolled 248 consecutive patients (44.8% male; mean age 79.0 ± 6.4 years) undergoing TAVR. In addition to demographic and clinical examination, blood parameters were recorded before TAVR, at discharge, 1 month and 1 year. Hemoglobin levels before TAVR 12.1 ± 1.8 g/dL, 10.8 ± 1.7 g/dL at discharge, 11.7 ± 1.7 g/dL at first month, 11.8 ± 1.4 g/dL at first year (Hemoglobin values compared with pre-TAVR, P < .001, P = .019, P = .047, respectively). Mean platelet volume (MPV) before TAVR 8.72 ± 1.71 fL, 8.16 ± 1.46 fL at discharge, 8.09 ± 1.44 fL at first month, 7.94 ± 1.18 fL at first year (MPV values compared with pre-TAVR, P < .001, P < .001, P < .001, respectively). Other hematologic parameters were also evaluated. Hemoglobin, platelet count, MPV, and red cell distribution width before the procedure, at discharge, and at the first year did not predict mortality and major bleeding in receiver operating characteristic analysis. After multivariate Cox regression analysis, hematologic parameters were not independent predictors of in-hospital mortality, major bleeding, and death at 1 year after TAVR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementHemoglobinsHumansMaleFemaleAgedAged, 80 and overPlatelet CountAortic Valve StenosisRisk FactorsTreatment OutcomeMean Platelet VolumeAortic Valve

Stichwörter der Autor:innen

aortic stenosishematologic parametershemoglobinmean platelet volumered cell distribution widthtranscatheter aortic valve implantation

Substanzen

Hemoglobins

Autor:innen und Institutionen

  • Department of Cardiology, Mardin Artuklu University Faculty of Medicine, Mardin, Turkey.
  • Department of Cardiology, Mardin Training and Research Hospital, Mardin, Turkey.
  • Department of Cardiology, Health Science University, Gazi Yaşargil Training and Research Hospital, Diyarbakır, Turkey.
  • Department of Cardiology, Memorial Diyarbakır Hospital, Diyarbakır, Turkey.
  • Department of Cardiology, Dicle University Faculty of Medicine, Diyarbakır, Turkey.

ORCID-Profile: Adem Aktan, Tuncay Güzel

Zitieren

APA

Karahan, M. Z., Aktan, A., Güzel, T., Kılıç, R., Günlü, S., Demir, M., & Ertaş, F. (2024). Evaluation of Hematological Parameters After Transcatheter Aortic Valve Replacement. Angiology. https://doi.org/10.1177/00033197231177397

Vancouver

Karahan MZ, Aktan A, Güzel T, Kılıç R, Günlü S, Demir M, et al. Evaluation of Hematological Parameters After Transcatheter Aortic Valve Replacement. Angiology. 2024. doi:10.1177/00033197231177397

BibTeX
@article{Karahan2024,
  author = {Karahan, Mehmet Zülküf and Aktan, Adem and Güzel, Tuncay and Kılıç, Raif and Günlü, Serhat and Demir, Muhammed and Ertaş, Faruk},
  title = {Evaluation of Hematological Parameters After Transcatheter Aortic Valve Replacement},
  journal = {Angiology},
  year = {2024},
  doi = {10.1177/00033197231177397}
}
Kostenlos starten →